-
Something wrong with this record ?
A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype
M. Hajkova, E. Javorkova, A. Zajicova, P. Trosan, V. Holan, M. Krulova,
Language English Country Great Britain
Document type Journal Article
Grant support
NT14102
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Medline Complete (EBSCOhost)
from 2012-01-01
PubMed
26118469
DOI
10.1002/term.2044
Knihovny.cz E-resources
- MeSH
- Allografts MeSH
- Cell Differentiation MeSH
- Cyclosporine pharmacology MeSH
- Macrophages metabolism MeSH
- Mesenchymal Stem Cells metabolism MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Graft Survival drug effects MeSH
- Skin Transplantation * MeSH
- Mesenchymal Stem Cell Transplantation * MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The immunosuppressive effects of systemically administered mesenchymal stem cells (MSCs) and immunosuppressive drugs have been well documented. We analysed the mechanisms underlying the therapeutic effect of MSCs applied locally in combination with non-specific immunosuppression in a mouse model of allogeneic skin transplantation. The MSC-seeded and cyclosporine A (CsA)-loaded nanofibre scaffolds were applied topically to skin allografts in a mouse model and the local immune response was assessed and characterized. MSCs migrated from the scaffold into the side of injury and were detected in the graft region and draining lymph nodes (DLNs). The numbers of graft-infiltrating macrophages and the production of nitric oxide (NO) were significantly decreased in recipients treated with MSCs and CsA, and this reduction correlated with impaired production of IFNγ in the graft and DLNs. In contrast, the proportion of alternatively activated macrophages (F4/80+CD206+cells) and the production of IL-10 by intragraft macrophages were significantly upregulated. The ability of MSCs to alter the phenotype of macrophages from the M1 type into an M2 population was confirmed in a co-culture system in vitro. We suggest that the topical application of MSCs in combination with CsA induces a switch in macrophages to a population with an alternatively activated 'healing' phenotype and producing elevated levels of IL-10. These alterations in macrophage phenotype and function could represent one of the mechanisms of immunosuppressive action of MSCs applied in combination with CsA. Copyright © 2015 John Wiley & Sons, Ltd.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18011347
- 003
- CZ-PrNML
- 005
- 20191118092105.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/term.2044 $2 doi
- 035 __
- $a (PubMed)26118469
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hajkova, Michaela $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic.
- 245 12
- $a A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype / $c M. Hajkova, E. Javorkova, A. Zajicova, P. Trosan, V. Holan, M. Krulova,
- 520 9_
- $a The immunosuppressive effects of systemically administered mesenchymal stem cells (MSCs) and immunosuppressive drugs have been well documented. We analysed the mechanisms underlying the therapeutic effect of MSCs applied locally in combination with non-specific immunosuppression in a mouse model of allogeneic skin transplantation. The MSC-seeded and cyclosporine A (CsA)-loaded nanofibre scaffolds were applied topically to skin allografts in a mouse model and the local immune response was assessed and characterized. MSCs migrated from the scaffold into the side of injury and were detected in the graft region and draining lymph nodes (DLNs). The numbers of graft-infiltrating macrophages and the production of nitric oxide (NO) were significantly decreased in recipients treated with MSCs and CsA, and this reduction correlated with impaired production of IFNγ in the graft and DLNs. In contrast, the proportion of alternatively activated macrophages (F4/80+CD206+cells) and the production of IL-10 by intragraft macrophages were significantly upregulated. The ability of MSCs to alter the phenotype of macrophages from the M1 type into an M2 population was confirmed in a co-culture system in vitro. We suggest that the topical application of MSCs in combination with CsA induces a switch in macrophages to a population with an alternatively activated 'healing' phenotype and producing elevated levels of IL-10. These alterations in macrophage phenotype and function could represent one of the mechanisms of immunosuppressive action of MSCs applied in combination with CsA. Copyright © 2015 John Wiley & Sons, Ltd.
- 650 _2
- $a alografty $7 D064591
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a cyklosporin $x farmakologie $7 D016572
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a přežívání štěpu $x účinky léků $7 D006085
- 650 _2
- $a makrofágy $x metabolismus $7 D008264
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a transplantace mezenchymálních kmenových buněk $7 D045164
- 650 _2
- $a mezenchymální kmenové buňky $x metabolismus $7 D059630
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 12
- $a transplantace kůže $7 D016038
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Javorková, Eliška $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic. Department of Transplantation Immunology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0300609
- 700 1_
- $a Zajícová, Alena $u Department of Transplantation Immunology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0105272
- 700 1_
- $a Trošan, Peter. $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic. Department of Transplantation Immunology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0242108
- 700 1_
- $a Holáň, Vladimír, $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic. Department of Transplantation Immunology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $d 1950- $7 nlk20050169384
- 700 1_
- $a Krulová, Magdaléna $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic. Department of Transplantation Immunology, Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 xx0083610
- 773 0_
- $w MED00163778 $t Journal of tissue engineering and regenerative medicine $x 1932-7005 $g Roč. 11, č. 5 (2017), s. 1456-1465
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26118469 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20191118092345 $b ABA008
- 999 __
- $a ok $b bmc $g 1288832 $s 1008159
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 11 $c 5 $d 1456-1465 $e 20150629 $i 1932-7005 $m Journal of tissue engineering and regenerative medicine $n J. tissue eng. regen. med. $x MED00163778
- GRA __
- $a NT14102 $p MZ0
- LZP __
- $a Pubmed-20180404